<DOC>
	<DOCNO>NCT02290691</DOCNO>
	<brief_summary>The purpose study determine administration flu vaccine use Needle-Free equivalent Needle Syringe administration measure laboratory test immune response .</brief_summary>
	<brief_title>Inactivated Influenza Via Jet Injection</brief_title>
	<detailed_description>Primary : To evaluate non-inferiority flu vaccine administer needle-free intramuscular ( IM ) injection versus needle syringe IM injection determine serum hemagglutination inhibition ( HAI ) reciprocal titer healthy adult 18-64 year . Secondary : To compare tolerability safety vaccine population base specifically solicited local systemic reaction occur 7 day post-immunization adverse event spontaneously report approximately 28 day post immunization .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adults age ≥ 18 ≤ 64 year age time enrollment Willing able give inform consent read consent form give adequate opportunity discus study investigator qualify designee Willing able adhere protocol require study procedure attend schedule visit Able receive trivalent influenza vaccine ( TIV ) quadrivalent influenza vaccine ( QIV ) base PI judgment Stable health status exclusionary medical neuropsychiatric condition determine screen evaluation base clinical judgment investigator qualify designee Access consistent mean telephone contact Presence febrile illness ( oral temperature &gt; 38 °C ) day immunization . Such subject reevaluate enrollment resolution illness Presence significant acute chronic uncontrolled medical neuropsychiatric illness /or presence significant condition may prohibit inclusion determine investigator qualify designee . Uncontrolled define : require institution new treatment within 1 month prior study enrollment change medication dosage month prior study enrollment Any known immunosuppressive condition include : history human immunodeficiency virus ( HIV ) infection , cancer cancer treatment within 3 year study enrollment , systemic glucocorticoid ( dose ≥10 mg prednisone daily equivalent 7 consecutive day 10 day total ) within 1 month study enrollment , cytotoxic immunosuppressive drug within 3 month study enrollment . Any significant disorder coagulation would increase risk intramuscular injection treatment Coumadin derivatives heparin Known suspect allergic egg , chicken protein , neomycin , polymyxin influenza vaccine History severe previous serious adverse reaction influenza vaccination Receipt immunoglobulin and/or blood product within 3 month immunization plan administration product study period Prior history demyelinate disease include GuillainBarre syndrome . Presence active neurological disorder History significant alcohol drug abuse within one year prior study enrollment Influenza vaccination laboratory confirm influenza infection within previous six month study vaccination plan influenza vaccination study period Planned administration noninfluenza vaccine 30 day prior study study period Pregnant plan become pregnant study period Currently enrol another vaccine drug study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Needle Free , Influenza</keyword>
</DOC>